Article
PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancer.
Cancer research - 15 Jun 2011
Urick Mary E, Rudd Meghan L, Godwin Andrew K, Sgroi Dennis, Merino Maria, Bell Daphne W
Abstract excerpt
Phosphoinositide 3-kinase (PI3K) is an important therapeutic target. Mutations in PIK3CA, which encodes p110α, the catalytic subunit of PI3K, occur in endometrioid endometrial cancers (EEC) and nonendometrioid endometrial cancers (NEEC). The goal of this study was to determine whether PIK3R1, which encodes p85α, the inhibitory subunit of PI3K, is mutated in endometrial carcinoma. We carried out exonic sequencing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
